Search Browse Earnings

FILANA THERAPEUTICS, INC. — SlamSEC

FILANA THERAPEUTICS, INC.

Nasdaq:SAVA

Pharmaceutical Preparations·AUSTIN, TX

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$2.0M

-34.1% YoY

FY 2015

Adj. EBITDA

-$80.0M

-4083.9% margin

FY 2024

Net Income

-$76.2M

-3894.1% margin

FY 2024

EPS (Diluted)

-$1.90

FY 2024

Stock Price

$2.37

+16.9%

2026-03-10

52W Range

$1.15 – $4.98

P/E Ratio

-1.2x

Market Cap

$114.4M

Cash

$121.1M

FY 2024

Total Debt

—

Net Cash

$121.1M

FY 2015

Enterprise Value

-$6.7M

Debt / EBITDA

1.5x

FY 2015

EV / EBITDA

0.1x

Employees

—

CEO

Barry Richard